Personalized measurable residual disease assays for acute myeloid leukemia guided by whole-genome sequencing
Niveditha Ravindra1, Rasha W Al-Ali2, Justin Lack3
1Laboratory of Myeloid Malignancies, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
Haematologica
|July 23, 2026
Abstract:
Not available.
